SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


National Association for Continuing Education
Course Directors
Gregg Sherman, MD
Chief Medical Officer, NACE
Plantation, FL

Deborah Paschal, CRNP
Philadelphia, PA

Medical Writer
Josh Kilbridge
Kilbride Associates Healthcare Communications
San Francisco, CA

Course Reviewer
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
Director, Riverside Diabetes Center
Riverside Medical Associates
Adjunct Assistant Professor
Uniformed Services
University of the Health Sciences
Bethesda, MD

Title
: Using Concentrated Insulins: A New Strategy for the Insulin-resistant Patient
Activity/Course #:
: NCME345
Cost:
: Free
Release/Start Date:
: Jan 15 2018
Expiration Date:
: Jan 14 2019
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Monograph
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes .75 pharmacology hour(s)
Hardware/Software Requirements:

Welcome to the National Association for Continuing Education monograph from the NACE Clinical Updates for NPs and PAs 2017 conference.

The global epidemic of obesity is contributing to an increasing prevalence of T2DM. This obesity is also associated with increasing insulin resistance, necessitating the use of higher insulin doses for achieving/maintaining glycemic control. Due to progressive β-cell dysfunction in T2DM, oral drugs such as metformin are often inadequate for achieving/maintaining glycemic control, and hence most patients will need insulin therapy for managing their disease, with early initiation being recommended for better outcomes. New preparations of concentrated, and long acting, insulins are available and may be appropriate for use in these situations. However, many clinicians are not familiar with these newer preparations and how to confidently utilize them.This educational program will discuss the differences between the available concentrated insulins, including their pharmacokinetic/pharmacodynamic profiles and other considerations for their use including the need for good provider-patient communication and proper patient education, which is particularly important to minimize dosing errors.

Learning Objective(s):

After completing this program participants should be able to:

  1. Describe the role of insulin therapy in patients with T2DM not meeting glycemic goals.
  2. Discuss the need for concentrated insulins in T2DM management.
  3. Discuss the pharmacokinetic/pharmacodynamic profiles and other considerations for the use of concentrated insulin preparations.
  4. Recognize the need for counseling patients about concentrated insulins to minimize dosing errors.

How to obtain the CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hours of continuing education (which includes 0.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Lucia Novak, MSN, ANP-BC, BC-ADM, CDTC is a speaker for Janssen Pharmaceuticals, Inc, Novo Nordisk, Inc and AstraZeneca Pharmaceuticals LP. Ms. Novak is a member on the Advisory Committee for Sanofi.

Gregg Sherman, MD, Course Director, has no relationships to disclose.

Deborah Paschal, CRNP, MD, Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an an educational grant from Sanofi US.